Skip to main content
Top

International Journal of Clinical Oncology

Issue 1/2017

Content (24 Articles)

Invited Review Article

Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis

Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi

Original Article

Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers

Tomohiro Matsuura, Yasumasa Nishimura, Kiyoshi Nakamatsu, Shuichi Kanamori, Kazuki Ishikawa, Izumi Tachibana, Makoto Hosono, Toru Shibata

Original Article

Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer

Yasuyuki Ikezawa, Jun Sakakibara-Konishi, Hidenori Mizugaki, Satoshi Oizumi, Masaharu Nishimura

Open Access Original Article

Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

Noboru Yamamoto, Koichi Goto, Makoto Nishio, Kenichi Chikamori, Toyoaki Hida, Makoto Maemondo, Nobuyuki Katakami, Toshiyuki Kozuki, Hiroshige Yoshioka, Takashi Seto, Kosei Tajima, Tomohide Tamura

Erratum

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

Noboru Yamamoto, Koichi Goto, Makoto Nishio, Kenichi Chikamori, Toyoaki Hida, Makoto Maemondo, Nobuyuki Katakami, Toshiyuki Kozuki, Hiroshige Yoshioka, Takashi Seto, Kosei Tajima, Tomohide Tamura

Original Article

Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer

Yuki Kitano, Masaaki Iwatsuki, Junji Kurashige, Daisuke Kuroda, Keisuke Kosumi, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto, Naoya Yoshida, Yoshio Haga, Hideo Baba

Original Article

Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea

Hiroyoshi Takemoto, Junichi Nishimura, Takamichi Komori, Ho Min Kim, Hirofumi Ota, Rei Suzuki, Masakazu Ikenaga, Masataka Ikeda, Hirofumi Yamamoto, Taroh Satoh, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Yuichirou Doki, Masaki Mori

Original Article

The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery

Ryosuke Okamura, Suguru Hasegawa, Koya Hida, Nobuaki Hoshino, Kenji Kawada, Kenichi Sugihara, Yoshiharu Sakai

Original Article

Psychological impact of positive cervical cancer screening results among Japanese women

Yukari Isaka, Haruhiko Inada, Yuri Hiranuma, Masao Ichikawa

Original Article

Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance

S. Krishna Priya, Kishore Kumar, K. R. Hiran, M. R. Bindhu, Rohit. P. Nagare, D. K. Vijaykumar, T. S. Ganesan

Original Article

Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors

Etsuko Miyagi, Yasuyo Maruyama, Tae Mogami, Reiko Numazaki, Atsuko Ikeda, Hiroshi Yamamoto, Fumiki Hirahara

Original Article

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy

Hiroki Ishihara, Takafumi Yagisawa, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe

Original Article

Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study

Hiroki Ishihara, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe

Original Article

Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer

Tsunenori Kondo, Isao Hara, Toshio Takagi, Yoshiki Kodama, Yasunobu Hashimoto, Hirohito Kobayashi, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Kazunari Tanabe

Original Article

The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy

Nozomu Kishimoto, Tetsuya Takao, Sohei Kuribayashi, Gaku Yamamichi, Kosuke Nakano, Masataka Kawamura, Koichi Tsutahara, Go Tanigawa, Seiji Yamaguchi

Original Article

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy

Hiromi Murasawa, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi

Original Article

A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial

Tomomi Kamba, Toshiyuki Kamoto, Shinichiro Maruo, Takashi Kikuchi, Yosuke Shimizu, Shunichi Namiki, Kiyohide Fujimoto, Hiroaki Kawanishi, Fuminori Sato, Shintaro Narita, Takefumi Satoh, Hideo Saito, Mikio Sugimoto, Jun Teishima, Naoya Masumori, Shin Egawa, Hideki Sakai, Yusaku Okada, Toshiro Terachi, Osamu Ogawa

Original Article

Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma

Shinya Morita, Yuji Nakamaru, Akihiro Homma, Shinichiro Yasukawa, Hiromitsu Hatakeyama, Tomohiro Sakashita, Satoshi Kano, Atsushi Fukuda, Satoshi Fukuda

Original Article

Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire

Amit Odelia, Joffe Erel, Perry Chava, Herishanu Yair, Sarid Nadav, Lishner Michael, Avivi Irit

Original Article

Nutritional care of cancer patients: a survey on patients’ needs and medical care in reality

J. Maschke, U. Kruk, K. Kastrati, J. Kleeberg, D. Buchholz, N. Erickson, J. Huebner

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine